Table 4 The results of univariate RFS analysis of clinical features.
From: Analysis of clinicopathologic and imaging features of dual-phenotype hepatocellular carcinoma
Clinical features | N | Recurrence | MRT (month) | HR (95%CI) | P | |
|---|---|---|---|---|---|---|
Gender | Male | 81 | 39 | 44 | 1.00 | |
Female | 14 | 6 | NA | 0.78 (0.33, 1.85) | 0.573 | |
Nationality | Han | 52 | 22 | NA | 1.00 | |
Zhuang | 43 | 23 | 31 | 1.69 (0.94, 3.05) | 0.078 | |
Age | < 47 years | 48 | 24 | 45 | 1.00 | |
≥ 47 years | 47 | 21 | NA | 0.90 (0.50, 1.62) | 0.737 | |
BMI | < 24 | 68 | 34 | 44 | 1.00 | |
≥ 24 | 27 | 11 | NA | 0.69 (0.35, 1.36) | 0.279 | |
Diameter | ≤ 4 cm | 45 | 16 | NA | 1.00 | |
> 4 cm | 50 | 29 | 18 | 2.05 (1.11, 3.78) | 0.019* | |
AFP | < 400 ng/ml | 55 | 18 | NA | 1.00 | |
≥ 400 ng/ml | 40 | 27 | 18 | 2.50 (1.37, 4.54) | 0.002** | |
CA199 | < 37 U/ml | 79 | 34 | NA | 1.00 | |
≥ 37 U/ml | 16 | 11 | 15 | 2.23 (1.12, 4.42) | 0.020* | |
HBsAg | ( −) | 15 | 6 | NA | 1.00 | |
( +) | 80 | 39 | 45 | 1.34 (0.57, 3.16) | 0.507 | |
Cirrhosis | No | 33 | 13 | NA | 1.00 | |
Yes | 62 | 32 | 41 | 1.32 (0.69, 2.52) | 0.394 | |
TACE | No | 58 | 29 | 44 | 1.00 | |
Yes | 37 | 16 | NA | 0.75 (0.41, 1.39) | 0.370 | |
